Physician profile
Heather Rivera
NPI 1801006598
$1,073.26
in general payments reported to CMS, 2019-2025
7 companies · $608 in 2025
The $608 reported for 2025 was more than what 80% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $232 · 2024: $233 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $327.87 | 2023-2025 | Fasenra, Andexxa |
| Gilead Sciences, INC. | $242.13 | 2023-2025 | Epclusa, Descovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.25 | 2024-2025 | Jardiance |
| Amgen INC. | $95.40 | 2024 | Repatha |
| Laborie Medical Technologies Corp. | $93.12 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $54.70 | 2025 | |
| Solventum Corporation | $26.79 | 2024 | V.A.C. Veraflo Cleanse Choice, V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.